{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:03:10Z","timestamp":1791360190284,"version":"4.3.1"},"reference-count":98,"publisher":"FapUNIFESP (SciELO)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["An. Bras. Dermatol."],"DOI":"10.1590\/abd1806-4841.20199007","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T16:21:35Z","timestamp":1557332495000},"page":"133-146","source":"Crossref","is-referenced-by-count":227,"title":["Bullous pemphigoid"],"prefix":"10.1590","volume":"94","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4133-4475","authenticated-orcid":false,"given":"Denise","family":"Miyamoto","sequence":"first","affiliation":[{"name":"Universidade de S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3650-4254","authenticated-orcid":false,"given":"Claudia Giuli","family":"Santi","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4256-4413","authenticated-orcid":false,"given":"Val\u00e9ria","family":"Aoki","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0541-5526","authenticated-orcid":false,"given":"Celina Wakisaka","family":"Maruta","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2019,5,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.autrev.2014.01.011","article-title":"Diagnosis and classification of pemphigus and bullous pemphigoid","volume":"13","author":"Kershenovich R","year":"2014","journal-title":"Autoimmun Rev"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.det.2011.03.008","article-title":"Pathogenesis of bullous pemphigoid","volume":"29","author":"Ujiie H","year":"2011","journal-title":"Dermatol Clin."},{"key":"ref3","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt E","year":"2013","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1111\/pde.12779","article-title":"Spectrum of Clinical Responses to Therapies in Infantile Bullous Pemphigoid","volume":"33","author":"Taquin H","year":"2016","journal-title":"Pediatr Dermatol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00403-014-1531-1","article-title":"Geographic variations in epidemiology of two autoimmune bullous diseases: pemphigus and bullous pemphigoid","volume":"307","author":"Alpsoy E","year":"2015","journal-title":"Arch Dermatol Res"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1365-4632.2009.04345.x","article-title":"Pemphigus vulgaris is the most common autoimmune bullous disease in Northwestern Romania","volume":"49","author":"Baican A","year":"2010","journal-title":"Int J Dermatol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"a180","DOI":"10.1136\/bmj.a180","article-title":"Bullous pemphigoid and pemphigus vulgaris--incidence and mortality in the UK: population based cohort study","volume":"337","author":"Langan SM","year":"2008","journal-title":"BMJ"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.1365-4632.2004.02292.x","article-title":"Spectrum of autoimmune bullous diseases in Kuwait","volume":"43","author":"Nanda A","year":"2004","journal-title":"Int J Dermatol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1046\/j.1365-2133.2002.04919.x","article-title":"Spectrum of subepidermal immunobullous disorders seen at the National Skin Centre, Singapore: a 2-year review","volume":"147","author":"Wong SN","year":"2002","journal-title":"Br J Dermatol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jaut.2016.06.019","article-title":"IgG4 autoantibodies are inhibitory in the autoimmune disease bullous pemphigoid","volume":"73","author":"Zuo Y","year":"2016","journal-title":"J Autoimmun"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00403-017-1789-1","article-title":"IgE autoantibodies and their association with the disease activity and phenotype in bullous pemphigoid: a systematic review","volume":"310","author":"Saniklidou AH","year":"2018","journal-title":"Arch Dermatol Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1111\/j.1398-9995.2009.02201.x","article-title":"Effects of omalizumab on markers of inflammation in patients with allergic asthma","volume":"64","author":"Holgate S","year":"2009","journal-title":"Allergy"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.jid.2017.11.031","article-title":"Eosinophils Mediate Tissue Injury in the Autoimmune Skin Disease Bullous Pemphigoid","volume":"138","author":"Lin L","year":"2018","journal-title":"J Invest Dermatol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"553","DOI":"10.4049\/jimmunol.1001753","article-title":"FcR-independent effects of IgE and IgG autoantibodies in bullous pemphigoid","volume":"187","author":"Messingham KN","year":"2011","journal-title":"J Immunol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1111\/jdv.13660","article-title":"Bullous pemphigoid and its association with neurological diseases: a systematic review and meta-analysis","volume":"30","author":"Lai YC","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1111\/bjd.15405","article-title":"Increased frequency of multiple sclerosis among patients with bullous pemphigoid: a population-based cohort study on comorbidities anchored around the diagnosis of bullous pemphigoid","volume":"176","author":"Kibsgaard L","year":"2017","journal-title":"Br J Dermatol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1365-2133.2011.10641.x","article-title":"Both bullous pemphigoid antigens are expressed in the central nervous system","volume":"166","author":"Seppanen AO","year":"2012","journal-title":"Br J Dermatol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jid.2016.09.010","article-title":"Increased Levels of the Bullous Pemphigoid BP180 Autoantibody Are Associated with More Severe Dementia in Alzheimer's Disease","volume":"137","author":"Kokkonen N","year":"2017","journal-title":"J Invest Dermatol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1016\/j.jid.2016.06.015","article-title":"Bullous Pemphigoid, Neurodegenerative Disease, and Hippocampal BP180 Expression: A Retrospective Postmortem Neuropathologic Study","volume":"136","author":"Barrick BJ","year":"2016","journal-title":"J Invest Dermatol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1111\/j.1365-2133.2009.09122.x","article-title":"Sera from patients with bullous pemphigoid (BP) associated with neurological diseases recognized BP antigen 1 in the skin and brain","volume":"160","author":"Li L","year":"2009","journal-title":"Br J Dermatol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0923-1811(94)00371-K","article-title":"The incidence of internal malignancies in pemphigus and bullous pemphigoid in Japan","volume":"9","author":"Ogawa H","year":"1995","journal-title":"J Dermatol Sci"},{"key":"ref22","first-page":"42","article-title":"The incidence of internal malignancies in autoimmune bullous diseases","volume":"32","author":"Iwashita K","year":"2007","journal-title":"Tokai J Exp Clin Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1001\/jamadermatol.2014.5263","article-title":"Association of Bullous Pemphigoid and Malignant Neoplasms","volume":"151","author":"Cai SC","year":"2015","journal-title":"JAMA Dermatol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/jid.2014.547","article-title":"Malignancies in pemphigus and pemphigoid diseases","volume":"135","author":"Schulze F","year":"2015","journal-title":"J Invest Dermatol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jaad.2017.05.006","article-title":"Association of bullous pemphigoid with malignancy: A systematic review and meta-analysis","volume":"77","author":"Atzmony L","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00403-013-1399-5","article-title":"Associations between bullous pemphigoid and primary malignant cancers: an English national record linkage study, 1999-2011","volume":"306","author":"Ong E","year":"2014","journal-title":"Arch Dermatol Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/1523-1747.ep12606974","article-title":"Increased expression of vascular permeability factor (vascular endothelial growth factor) in bullous pemphigoid, dermatitis herpetiformis, and erythema multiforme","volume":"104","author":"Brown LF","year":"1995","journal-title":"J Invest Dermatol"},{"key":"ref28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129456","article-title":"Activation of Blood Coagulation in Two Prototypic Autoimmune Skin Diseases: A Possible Link with Thrombotic Risk","volume":"10","author":"Cugno M","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1182\/blood-2006-02-004945","article-title":"Eosinophils are a major intravascular location for tissue factor storage and exposure","volume":"109","author":"Moosbauer C","year":"2007","journal-title":"Blood"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1161\/STROKEAHA.110.596361","article-title":"Increased risk of stroke in patients with bullous pemphigoid: a population-based follow-up study","volume":"42","author":"Yang YW","year":"2011","journal-title":"Stroke"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/archderm.134.4.465","article-title":"High risk of death in elderly patients with extensive bullous pemphigoid","volume":"134","author":"Roujeau JC","year":"1998","journal-title":"Arch Dermatol"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000350285","article-title":"A case of lichen planus pemphigoides successfully treated with a combination of cyclosporine a and prednisolone","volume":"5","author":"Washio K","year":"2013","journal-title":"Case Rep Dermatol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jaad.2017.10.035","article-title":"Nonbullous pemphigoid: A systematic review","volume":"78","author":"Lamberts A","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1111\/ijd.13034","article-title":"Exfoliative erythroderma as a clinical manifestation of autoimmune bullous diseases","volume":"55","author":"Miyamoto D","year":"2016","journal-title":"Int J Dermatol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/archderm.136.4.527","article-title":"Bullous pemphigoid of childhood: autoantibodies target the same epitopes within the NC16A domain of BP180 as autoantibodies in bullous pemphigoid of adulthood","volume":"136","author":"Chimanovitch I","year":"2000","journal-title":"Arch Dermatol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jaad.2007.08.010","article-title":"Bullous pemphigoid in infancy: Clinical and epidemiologic characteristics","volume":"58","author":"Waisbourd-Zinman O","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1346-8138.2005.tb00912.x","article-title":"Childhood bullous pemphigoid: report of three cases","volume":"32","author":"Voltan E","year":"2005","journal-title":"J Dermatol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1046\/j.1365-4362.1998.00615.x","article-title":"Bullous pemphigoid in a 2-month-old infant","volume":"37","author":"Cunha PR","year":"1998","journal-title":"Int J Dermatol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1684\/ejd.2016.2909","article-title":"Bullous pemphigoid in infancy with spontaneous remission","volume":"27","author":"Nomura H","year":"2017","journal-title":"Eur J Dermatol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00000372-200306000-00001","article-title":"Childhood bullous pemphigoid: a clinicopathologic study and review of the literature","volume":"25","author":"Fisler RE","year":"2003","journal-title":"Am J Dermatopathol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-2133.1976.tb00865.x","article-title":"Bullous pemphigoid and psoriasis: does subclinical bullous pemphigoid exist?","volume":"95","author":"Person JR","year":"1976","journal-title":"Br J Dermatol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/j.1365-4632.2006.02861.x","article-title":"Concomitant psoriasis and bullous pemphigoid: coincidence or pathogenic relationship?","volume":"45","author":"Wilczek A","year":"2006","journal-title":"Int J Dermatol"},{"key":"ref43","first-page":"283","article-title":"A case of bullous pemphigoid limited to psoriatic plaques","volume":"70","author":"Kobayashi TT","year":"2002","journal-title":"Cutis"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0190-9622(98)70414-1","article-title":"Psoriasis and bullous pemphigoid treated with azathioprine","volume":"39","author":"Primka 3rd EJ","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/BF00374209","article-title":"UVB irradiation reduces the expression of pemphigoid antigens in organ-cultured normal human skin","volume":"286","author":"Muramatsu T","year":"1994","journal-title":"Arch Dermatol Res"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0952-7915(96)80012-4","article-title":"Epitope spreading","volume":"8","author":"Vanderlugt CJ","year":"1996","journal-title":"Curr Opin Immunol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/bjd.13097","article-title":"A case of lichen planus pemphigoides with autoantibodies to the NC16a and C-terminal domains of BP180 and to desmoglein-1","volume":"171","author":"Sekiya A","year":"2014","journal-title":"Br J Dermatol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.autrev.2015.01.006","article-title":"Atypical presentations of bullous pemphigoid: Clinical and immunopathological aspects","volume":"14","author":"Cozzani E","year":"2015","journal-title":"Autoimmun Rev"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/jdv.12366","article-title":"Drug-induced pemphigoid: a review of the literature","volume":"28","author":"Stavropoulos PG","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref50","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2018.09.048","article-title":"Dipeptidyl-peptidase IV inhibitor-associated bullous pemphigoid: A systematic review and meta-analysis","author":"Kridin K","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/2013.jamadermatol.376","article-title":"The associations between bullous pemphigoid and drug use: a UK case-control study","volume":"149","author":"Lloyd-Lavery A","year":"2013","journal-title":"JAMA Dermatol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/jid.2010.301","article-title":"Risk factors for bullous pemphigoid in the elderly: a prospective case-control study","volume":"131","author":"Bastuji-Garin S","year":"2011","journal-title":"J Invest Dermatol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/ijd.13984","article-title":"A review of bullous pemphigoid associated with PD-1 and PD-L1 inhibitors","volume":"57","author":"Lopez AT","year":"2018","journal-title":"Int J Dermatol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/bjd.14601","article-title":"Bullous pemphigoid and dipeptidyl peptidase IV inhibitors: a case-noncase study in the French Pharmacovigilance Database","volume":"175","author":"B\u00e9n\u00e9 J","year":"2016","journal-title":"Br J Dermatol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.jid.2017.11.023","article-title":"HLA-DQB1*03:01 as a Biomarker for Genetic Susceptibility to Bullous Pemphigoid Induced by DPP-4 Inhibitors","volume":"138","author":"Ujiie H","year":"2018","journal-title":"J Invest Dermatol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jaad.2017.12.038","article-title":"Dipeptidyl peptidase IV inhibitors, a risk factor for bullous pemphigoid: Retrospective multicenter case-control study from France and Switzerland","volume":"78","author":"Benzaquen M","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1158\/2326-6066.CIR-15-0123","article-title":"Autoimmune Bullous Skin Disorders with Immune Checkpoint Inhibitors Targeting PD-1 and PD-L1","volume":"4","author":"Naidoo J","year":"2016","journal-title":"Cancer Immunol Res"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s40257-017-0336-3","article-title":"Dermatologic Reactions to Immune Checkpoint Inhibitors: Skin Toxicities and Immunotherapy","volume":"19","author":"Sibaud V","year":"2018","journal-title":"Am J Clin Dermatol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000489661","article-title":"Bullous Pemphigoid as an Adverse Reaction to Pembrolizumab: Two Case Reports","volume":"10","author":"Thomsen K","year":"2018","journal-title":"Case Rep Dermatol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1634\/theoncologist.2018-0128","article-title":"A Case of Nivolumab-Induced Bullous Pemphigoid: Review of Dermatologic Toxicity Associated with Programmed Cell Death Protein-1\/Programmed Death Ligand-1 Inhibitors and Recommendations for Diagnosis and Management","volume":"23","author":"Lopez AT","year":"2018","journal-title":"Oncologist"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jaad.2011.06.032","article-title":"Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts","volume":"66","author":"Murrell DF","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"ref62","first-page":"4","article-title":"Introducing a novel Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) in pemphigus","volume":"17","author":"Pf\u00fctze M","year":"2007","journal-title":"Eur J Dermatol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2340\/00015555-2473","article-title":"The Reliability, Validity and Responsiveness of Two Disease Scores (BPDAI and ABSIS) for Bullous Pemphigoid: Which One to Use?","volume":"97","author":"Wijayanti A","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.jaad.2013.07.009","article-title":"Comparative study of direct and indirect immunofluorescence and of bullous pemphigoid 180 and 230 enzyme-linked immunosorbent assays for diagnosis of bullous pemphigoid","volume":"69","author":"S\u00e1rdy M","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1001\/archderm.1991.01680030098014","article-title":"Childhood bullous pemphigoid: Clinical and immunologic features, treatment, and prognosis","volume":"127","author":"Nemeth AJ","year":"1991","journal-title":"Arch Dermatol"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1111\/jdv.14312","article-title":"Multimorbidity in bullous pemphigoid: a case-control analysis of bullous pemphigoid patients with age- and gender-matched controls","volume":"31","author":"Sim B","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1001\/jamadermatol.2016.3357","article-title":"Correlation of Serum Levels of IgE Autoantibodies Against BP180 With Bullous Pemphigoid Disease Activity","volume":"153","author":"van Beek N","year":"2017","journal-title":"JAMA Dermatol"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/1346-8138.14503","article-title":"Mortality in bullous pemphigoid: A systematic review and meta-analysis of standardized mortality ratios","volume":"45","author":"Kridin K","year":"2018","journal-title":"J Dermatol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/bjd.14821","article-title":"Hospitalization, inpatient burden and comorbidities associated with bullous pemphigoid in the U.S.A","volume":"176","author":"Ren Z","year":"2017","journal-title":"Br J Dermatol"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1001\/jamadermatol.2017.2808","article-title":"Determining the Incidence of Pneumocystis Pneumonia in Patients With Autoimmune Blistering Diseases Not Receiving Routine Prophylaxis","volume":"153","author":"Amber KT","year":"2017","journal-title":"JAMA Dermatol"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00403-017-1736-1","article-title":"Prognostic factors for mortality in patients with bullous pemphigoid: a meta-analysis","volume":"309","author":"Liu YD","year":"2017","journal-title":"Arch Dermatol Res"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/bjd.16553","article-title":"Prospective study in bullous pemphigoid: association of high serum anti-BP180 IgG levels with increased mortality and reduced Karnofsky score","volume":"179","author":"Holtsche MM","year":"2018","journal-title":"Br J Dermatol"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/j.0022-202X.2005.23626.x","article-title":"Response to: mortality rate of bullous pemphigoid in a US medical center","volume":"124","author":"Joly P","year":"2005","journal-title":"J Invest Dermatol"},{"key":"ref74","first-page":"72","article-title":"Mortality in Patients with Bullous Pemphigoid: A Retrospective Cohort Study, Systematic Review and Meta-analysis","volume":"99","author":"Kridin K","year":"2018","journal-title":"Acta Derm Venereol"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"xx","DOI":"10.1111\/j.0022-202X.2005.23677.x","article-title":"Why is the mortality of bullous pemphigoid greater in Europe than in the US?","volume":"124","author":"Bystryn JC","year":"2005","journal-title":"J J Invest Dermatol"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/bjd.15649","article-title":"An open, multicentre, randomized clinical study in patients with bullous pemphigoid comparing methylprednisolone and azathioprine with methylprednisolone and dapsone","volume":"177","author":"Sticherling M","year":"2017","journal-title":"Br J Dermatol"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/S0140-6736(17)30560-3","article-title":"Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial","volume":"389","author":"Williams HC","year":"2017","journal-title":"Lancet"},{"key":"ref78","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002292.pub3","article-title":"Interventions for bullous pemphigoid","author":"Kirtschig G","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa011592","article-title":"A comparison of oral and topical corticosteroids in patients with bullous pemphigoid","volume":"346","author":"Joly P","year":"2002","journal-title":"N Engl J Med"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/jid.2008.412","article-title":"A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized study","volume":"129","author":"Joly P","year":"2009","journal-title":"J Invest Dermatol"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1346-8138.2003.tb00353.x","article-title":"Treatment of bullous pemphigoid","volume":"30","author":"Fontaine J","year":"2003","journal-title":"J Dermatol"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1111\/bjd.12072","article-title":"British Association of Dermatologists' guidelines for the management of bullous pemphigoid 2012","volume":"167","author":"Venning VA","year":"2012","journal-title":"Br J Dermatol"},{"key":"ref83","first-page":"833","article-title":"S2k guidelines for the treatment of pemphigus vulgaris\/foliaceus and bullous pemphigoid","volume":"13","author":"Eming R","year":"2015","journal-title":"J Dtsch Dermatol Ges"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/bjd.13717","article-title":"Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology","volume":"172","author":"Feliciani C","year":"2015","journal-title":"Br J Dermatol"},{"key":"ref85","first-page":"925","article-title":"Treatment of bullous pemphigoid with prednisolone only: 0.75 mg\/kg\/day versus 1.25 mg\/kg\/day. A multicenter randomized study","volume":"111","author":"Morel P","year":"1984","journal-title":"Ann Dermatol Venereol"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.clindermatol.2011.03.013","article-title":"Immunosuppressive therapy for autoimmune bullous diseases","volume":"30","author":"Meurer M","year":"2012","journal-title":"Clin Dermatol"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1046\/j.1365-2249.2001.01503.x","article-title":"The IL-8 release from cultured human keratinocytes, mediated by antibodies to bullous pemphigoid autoantigen 180, is inhibited by dapsone","volume":"124","author":"Schmidt E","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.phrs.2010.10.007","article-title":"Clinical applications of non-antimicrobial tetracyclines in dermatology","volume":"63","author":"Monk E","year":"2011","journal-title":"Pharmacol Res"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/S0140-6736(17)30549-4","article-title":"Doxycycline: a first-line treatment for bullous pemphigoid?","volume":"389","author":"Grantham HJ","year":"2017","journal-title":"Lancet"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1172\/JCI24394","article-title":"Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases","volume":"115","author":"Li N","year":"2005","journal-title":"J Clin Invest"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jid.2018.02.020","article-title":"Modes of Action of Intravenous Immunoglobulin in Bullous Pemphigoid","volume":"138","author":"Li N","year":"2018","journal-title":"J Invest Dermatol"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jdermsci.2016.11.003","article-title":"A randomized double-blind trial of intravenous immunoglobulin for bullous pemphigoid","volume":"85","author":"Amagai M","year":"2017","journal-title":"J Dermatol Sci"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/sonc.2003.50025","article-title":"The mechanisms of action of rituximab in the elimination of tumor cells","volume":"30","author":"Johnson P","year":"2003","journal-title":"Semin Oncol"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jdermsci.2013.11.014","article-title":"Rituximab decreases without preference all subclasses of IgG anti-BP180 autoantibodies in refractory bullous pemphigoid (BP)","volume":"74","author":"Ronaghy A","year":"2014","journal-title":"J Dermatol Sci"},{"key":"ref95","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jaad.2015.11.030","article-title":"Treatment of recalcitrant bullous pemphigoid (BP) with a novel protocol: A retrospective study with a 6-year follow-up","volume":"74","author":"Ahmed AR","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"ref96","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jim.2009.04.013","article-title":"A novel ELISA reveals high frequencies of BP180-specific IgE production in bullous pemphigoid","volume":"346","author":"Messingham KA","year":"2009","journal-title":"J Immunol Methods"},{"key":"ref97","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/j.1365-2133.2011.10481.x","article-title":"Detection of linear IgE deposits in bullous pemphigoid and mucous membrane pemphigoid: a useful clue for diagnosis","volume":"165","author":"Yayli S","year":"2011","journal-title":"Br J Dermatol"},{"key":"ref98","first-page":"328","article-title":"Bullous pemphigoid: clinical practice guidelines","volume":"105","author":"Fuertes de Vega I","year":"2014","journal-title":"Actas Dermosifiliogr"}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/abd\/v94n2\/0365-0596-abd-94-02-0133.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T11:00:46Z","timestamp":1747652446000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0365-05962019000200133&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,9]]},"references-count":98,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,4]]}},"alternative-id":["S0365-05962019000200133"],"URL":"https:\/\/doi.org\/10.1590\/abd1806-4841.20199007","relation":{},"ISSN":["1806-4841","0365-0596"],"issn-type":[{"value":"1806-4841","type":"electronic"},{"value":"0365-0596","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5,9]]}}}